GlassScriptPhysician profile
Steve Hong
NPI 1093152639
$11,155.08
in general payments reported to CMS, 2019-2025
37 companies · $556 in 2025
The $556 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,849 · 2020: $1,473 · 2021: $1,284 · 2022: $982 · 2023: $1,957 · 2024: $1,054 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,560 · Travel and Lodging: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.28 |
| Travel and Lodging | $1,006.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,156.58 | 2019-2025 | Proclaim, Eterna, Penta |
| Si-Bone, INC. | $2,235.84 | 2019-2021 | |
| Boston Scientific Corporation | $1,593.94 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $829.28 | 2021-2024 | Venaseal |
| Nevro Corp. | $612.65 | 2019-2021 | |
| Medtronic USA, INC. | $502.88 | 2019-2020 | |
| Curonix LLC | $422.74 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $299.65 | 2024-2025 | |
| Stryker Corporation | $192.29 | 2023-2025 | Mild Device Kit, Inspace, Champion |
| Vertiflex, INC. | $188.76 | 2019 | |
| Cerapedics INC. | $140.84 | 2022 | |
| Innovation Technologies INC | $109.97 | 2023 | Irrisept |
| Nalu Medical, INC. | $99.33 | 2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $83.77 | 2020-2024 | Exparel, Zilretta, Iovera |
| Bioventus LLC | $76.98 | 2020-2025 | Exogen Ultrasound Bone Healing System, Durolane |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.